SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Spire Global, Inc. collects space-based data using a proprietary constellation of low earth multi-use receiver nanosatellites. Its software analytics generate proprietary data, insights and predictive analytics for its customers through a subscription model. The company was founded by Peter Platzer in August 2012 and is headquartered in Vienna, VA.

Spire Global Inc - Ordinary Shares - Class A

Spire Global is gaining significant momentum as investors rotate into the space and defense sector, fueled by major contract wins like the recent Missile Defense Agency SHIELD IDIQ. The community is actively debating the stock's growth trajectory and fundamental potential while closely monitoring institutional accumulation and potential short squeeze dynamics amid heightened volatility.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is experiencing a severe structural sell-off as investors aggressively de-risk from SaaS stocks amid rising fears that AI agents could disrupt enterprise software workflows. While some market participants are attempting to bottom-fish based on the company's deeply embedded position in corporate infrastructure, others remain deeply skeptical, citing ongoing institutional exits and negative sentiment surrounding valuation multiples and competitive threats.

The Mosaic Co. engages in the production and marketing of concentrated phosphate and potash crop nutrients. It operates through the following segments: Phosphates, Potash, and Mosaic Fertilizantes. The Phosphates segment is involved in the ownership and operation of mines and production facilities which produce concentrated phosphate crop nutrients and phosphate-based animal feed ingredients, and processing plants which produce concentrated phosphate crop nutrients. The Potash segment includes mining, processing, and selling potash. The Mosaic Fertilizantes segment focuses on mines, chemical plants, crop nutrient blending and bagging facilities, port terminals, and warehouses. The company was founded on March 25, 2004 and is headquartered in Tampa, FL.

Mosaic Company

Mosaic is trending as investors weigh persistent supply-chain riskscompounded by Middle East tensions and shifting trade policyagainst the company's valuation as a major North American real-asset producer. The community remains heavily divided between those viewing the stock as a deeply undervalued play on critical agricultural inputs and food security, and skeptics wary of margin pressures, geopolitical headlines, and ongoing analyst downgrades.

Barrick Mining Corp. engages in the production and sale of gold, copper, and related activities. It also provides exploration and mining development. It operates through the following business segments: Carlin, Cortez, Turquoise Ridge, Pueblo Viejo, Loulo-Gounkoto, Kibali, Veladero, North Mara, Bulyanhulu, and Other Mines. The company was founded by Peter D. Munk in 1983 and is headquartered in Toronto, Canada.

Barrick Mining Corp.

Barrick Mining Corp

Barrick Mining is currently capturing significant investor attention as gold prices hit historic highs, fueling speculation about long-term valuation shifts and potential production expansions at its Reko Diq and Four Mile projects. Community discussion is heavily focused on whether the company's recent operational updates and strategic focus on value maximization through a proposed North American assets IPO will successfully unlock latent value amid the ongoing gold bull cycle.

Maulcoin

Maulcoin is trending as the community celebrates the successful recovery of its ticker and actively campaigns to increase market visibility and liquidity. Supporters are rallying around the project's transparent, organic growth model, framing it as an alternative to typical high-risk meme coin volatility.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir Technologies is experiencing heightened volatility driven by a rare public endorsement from President Trump, which has sparked intense debate between investors viewing it as a critical defense infrastructure play and those following bearish narratives from figures like Michael Burry. Community discourse is sharply divided between tactical traders attempting to capitalize on the political headlines and long-term believers defending the company's entrenchment within government and military AI operations despite ongoing valuation concerns.

Sezzle, Inc. engages in the operation of a digital payment platform that enables bank-to-bank transfer of money between consumers and businesses. The company was founded by Charlie G. Youakim, Killian Brackey and Paul V. Paradis on January 4, 2016 and is headquartered in Minneapolis, MN.

Sezzle Inc.

Sezzle is seeing significant volatility following the abrupt resignation of a board member who cited major friction with management regarding strategy and corporate governance. While the stock has faced downward pressure, the community remains divided between those viewing the internal shakeup as a red flag and others focusing on strong underlying fundamentals and the potential for a short squeeze as the company continues its pivot toward a broader financial services platform.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing significant upward momentum and volatility following a massive patent settlement that removes a long-standing legal overhang, combined with positive regulatory progress for its combined COVID-19 and flu vaccine. The community is actively debating the stock's potential for a major short squeeze given the substantial short interest and bullish sentiment surrounding its expanding oncology pipeline and partnership with Merck.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending due to strong momentum in its HIV franchise, bolstered by the expansion of its treatment pipeline and strategic moves to secure long-term market exclusivity for key products. Community discussion is heavily focused on the company's aggressive M&A appetite in the oncology and cell therapy sectors, with investors closely watching for potential acquisitions that could further diversify its growth beyond established cash flows.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

The KraneShares CSI China Internet ETF ($KWEB) is trending as investors weigh aggressive call option activity against market volatility surrounding recent U.S.-China trade developments and evolving regulatory shifts in the Chinese tech sector. Community sentiment is deeply polarized, with many market participants viewing the current valuation as a multi-year accumulation opportunity driven by AI infrastructure investment, while others remain cautious regarding macro headwinds and persistent geopolitical uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company was founded by Sangwoo Park in 2017 and is headquartered in Santa Ana, CA.

GFOR
Graf Acquisition Corp IV

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest GFOR News

GFORGraf Acquisition Corp IV